Preferred subcutaneous sites include the abdomen and the outer upper arms, providing straightforward access for individuals administering their own injections: Abdomen: Injections are given at least two inches away from the navel, allowing for a broad area of fat tissue
5-Amino-1MQ is a novel peptide that inhibits the activity of nicotinamide N-methyltransferase (NNMT), an enzyme linked to obesity and metabolic disorders
Lipo B12 (MIC) injection for fat loss
Objective and subjective 5-Amino-1MQ results Result type Objective Examples Body weight, waist size, body-fat estimate, blood markers Main limit Measurements can still change with hydration, device error, and testing conditions
A finished capsule or spray should be evaluated using testing metrics that confirm both the identity of the peptide and the amount of peptide present in the final formulation
An initial 4-8 week assessment period allows evaluation of individual response and tolerance before committing to extended therapy